Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02038244
Other study ID # 135393-BO
Secondary ID
Status Completed
Phase N/A
First received January 9, 2014
Last updated September 22, 2015
Start date February 2014
Est. completion date March 2015

Study information

Verified date May 2015
Source Universität Duisburg-Essen
Contact n/a
Is FDA regulated No
Health authority Germany: Universität Duisburg-Essen
Study type Interventional

Clinical Trial Summary

In this study, the effects of a 14-day inpatient treatment in an internal medicine ward for integrative medicine on pain, disability, quality of life, satisfaction with life, depression, and anxiety will be investigated. Furthermore the influence of potential process variables will be evaluated.

Effects will be measured after completion of the program (2 weeks), and at 6 months follow up after start of the program.


Recruitment information / eligibility

Status Completed
Enrollment 300
Est. completion date March 2015
Est. primary completion date September 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- diagnosed with any chronic pain condition

- at least 6 months pain duration

- written informed consent

Exclusion Criteria:

- participation in any other clinical study

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Multimodal integrative medicine inpatient treatment program


Locations

Country Name City State
Germany Department of Internal and Integrative Medicine, Kliniken Essen-Mitte Essen

Sponsors (2)

Lead Sponsor Collaborator
Universität Duisburg-Essen University of Witten/Herdecke

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Other Body awareness Translated body awareness questionnaire will be validated. It will further be used for mediation and moderator analysis with the outcomes.
- Body Awareness Questionnaire (BAQ) (Shields 1989)
14 days, 6 months No
Other Body responsiveness Translated body awareness questionnaire will be validated. It will further be used for mediation and moderator analysis with the outcomes.
Body Responsiveness Scale (BRS)(Daubenmier 2005)
14 days, 6 months No
Other Body awareness and dissociation Translated body awareness questionnaire will be validated. It will further be used for mediation and moderator analysis with the outcomes.
- Scale of Body Connection (SBC) (Price and Thompson 2007)
14 days, 6 months No
Other Postural awareness Newly developed body awareness questionnaire will be validated. It will further be used for mediation and moderator analysis with the outcomes.
- Postural Awareness Scale (PAS) (Cramer et al.)
14 days, 6 months No
Other Body awareness The DKB will be used for mediation and moderator analysis with the outcomes and for validation purposes.
- Dresden Body Image Questionnaire (DKB) (Pöhlmann et al., 2007)
14 days, 6 months No
Other Daily log Daily rating of pain and well-being on a 100mm visual analog scale. 2 weeks No
Primary Pain Intensity VAS 14 days No
Secondary Pain Intensity VAS 6 months No
Secondary Pain Disability - German Pain Questionnaire 14 days, 6 months No
Secondary Health-related quality of life Short Form (36) Health Survey 14 days, 6 months No
Secondary Life satisfaction Brief Multidimensional Life Satisfaction Scale 14 days, 6 months No
Secondary Depression Beck Depression Inventory 14 days, 6 months No
Secondary Acceptance Emotional/Rational Disease Acceptance Questionnaire 14 days, 6 months No
Secondary Mindfulness Conscious Presence and Self Control (CPSC) Scale 14 days, 6 months No
Secondary Subjective stress Perceived Stress Scale 14 days, 6 months No
Secondary Easiness of life Questionnaire on emotional and physical reactions 14 days, 6 months No
Secondary Ability and will to change Ability and will to change Questionnaire 14 days, 6 months No
Secondary Safety Adverse events 14 days, 6 months Yes
Secondary Pain Disability - Pain Disability Index 14 days, 6 months No
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain